Similar articles

Abstract: Activated nuclear factor-κ;b (NF-κ;b) plays an important role in the development of cardiovascular disease (CVD) through its regulated genes and microRNAs (miRNAs). However, the gene regulation profile remains unclear. In this study, primary mouse vascular endothelial cells (pMVECs) were employed to detect CVD-related NF-κB-regulated genes and miRNAs. Genechip assay identified 77 NF-κB-regulated genes, including 45 upregulated and 32 downregulated genes, in tumor necrosis factor α (TNFα)-treated pMVECs. Ten of these genes were also found to be regulated by NF-κB in TNFα-treated HeLa cells. Quantitative real-time PCR (qRT-PCR) assay confirmed the up-regulation of Egr1, Tnf, and Btg2 by NF-κB in the TNFα-treated pMVECs. The functional annotation revealed that many NF-κB-regulated genes identified in pMVECs were clustered into classical NF-κB-involved biological processes. Genechip assay also identified 26 NF-κB-regulated miRNAs, of which 21 were upregulated and 5 downregulated, in the TNFα-treated pMVECs. Further analysis showed that nine of the identified genes are regulated by seven of these miRNAs. Finally, among the identified NF-κB-regulated genes and miRNAs, 5 genes and 12 miRNAs were associated with CVD by miRWalk and genetic association database analysis. Taken together, these findings show an intricate gene regulation network raised by NF-κB in TNFα-treated pMVECs. The network provides new insights for understanding the molecular mechanism underlying the progression of CVD.

基于TNFα处理的小鼠原代血管内皮细胞鉴定心血管疾病相关的NF-κB调控的基因和microRNA

[1]Becker KG, Barnes KC, Bright TJ, et al., 2004. The genetic association database. Nat Genet, 36(5):431-432.

[2]Bond M, Fabunmi RP, Baker AH, et al., 1998. Synergistic upregulation of metalloproteinase-9 by growth factors and inflammatory cytokines: an absolute requirement for transcription factor NF-κB. FEBS Lett, 435(1):29-34.

[3]Borghaei RC, Rawlings PL Jr, Javadi M, et al., 2004. NF-κB binds to a polymorphic repressor element in the MMP-3 promoter. Biochem Biophys Res Commun, 316(1):182-188.

[4]Boulanger CM, 1999. Secondary endothelial dysfunction: hypertension and heart failure. J Mol Cell Cardiol, 31(1):39-49.

[5]Chen L, Wang FY, Zeng ZY, et al., 2017. MicroRNA-199a acts as a potential suppressor of cardiomyocyte autophagy through targeting Hspa5. Oncotarget, 8(38):63825-63834.

[6]https://doi.org/10.18632/oncotarget.19133

[7]Chen R, Alvero AB, Silasi DA, et al., 2008. Regulation of IKKβ by miR-199a affects NF-κB activity in ovarian cancer cells. Oncogene, 27(34):4712-4723.

[8]Chistiakov DA, Sobenin IA, Orekhov AN, et al., 2015. Human miR-221/222 in physiological and atherosclerotic vascular remodeling. Biomed Res Int, 2015:354517.

[9]Collart MA, Baeuerle P, Vassalli P, 1990. Regulation of tumor necrosis factor alpha transcription in macrophages: involvement of four κB-like motifs and of constitutive and inducible forms of NF-κB. Mol Cell Biol, 10(4):1498-1506.

[10]Dweep H, Sticht C, Pandey P, et al., 2011. miRWalk–database: prediction of possible miRNA binding sites by “walking” the genes of three genomes. J Biomed Inform, 44(5):839-847.

[11]Estruch R, 2014. Cardiovascular mortality: how can it be prevented? Nefrologia, 34(5):561-569.

[12]Frantz S, Ertl G, Bauersachs J, 2007. Mechanisms of disease: Toll-like receptors in cardiovascular disease. Nat Clin Pract Cardiovasc Med, 4(8):444-454.

[13]Galardi S, Mercatelli N, Farace MG, et al., 2011. NF-κB and c-Jun induce the expression of the oncogenic miR-221 and miR-222 in prostate carcinoma and glioblastoma cells. Nucleic Acids Res, 39(9):3892-3902.

[14]Hein H, Schlüter C, Kulke R, et al., 1997. Genomic organization, sequence, and transcriptional regulation of the human eotaxin gene. Biochem Biophys Res Commun, 237(3):537-542.

[15]Hullinger TG, Montgomery RL, Seto AG, et al., 2012. Inhibition of miR-15 protects against cardiac ischemic injury. Circ Res, 110(1):71-81.

[16]Iademarco MF, McQuillan JJ, Rosen GD, et al., 1992. Characterization of the promoter for vascular cell adhesion molecule-1 (VCAM-1). J Biol Chem, 267(23):16323-16329.

[17]Lerman A, Zeiher AM, 2005. Endothelial function: cardiac events. Circulation, 111(3):363-368.

[18]Li YX, Song YH, Li F, et al., 2009. MicroRNA-221 regulates high glucose-induced endothelial dysfunction. Biochem Biophys Res Commun, 381(1):81-83.

[19]Li Z, Song Y, Liu L, et al., 2017. miR-199a impairs autophagy and induces cardiac hypertrophy through mTOR activation. Cell Death Differ, 24(7):1205-1213.

[20]Lim YC, Garcia-Cardena G, Allport JR, et al., 2003. Heterogeneity of endothelial cells from different organ sites in T-cell subset recruitment. Am J Pathol, 162(5):1591-1601.

[21]Liu YX, Wang JK, 2013. Effects of DMSA-coated Fe₃O₄ nanoparticles on the transcription of genes related to iron and osmosis homeostasis. Toxicol Sci, 131(2):521-536.

[22]Ma XD, Becker Buscaglia LE, Barker JR, et al., 2011. MicroRNAs in NF-κB signaling. J Mol Cell Biol, 3(3):159-166.

[23]Madamanchi NR, Vendrov A, Runge MS, 2005. Oxidative stress and vascular disease. Arterioscler Thromb Vasc Biol, 25(1):29-38.

[24]Mangge H, Becker K, Fuchs D, et al., 2014. Antioxidants, inflammation and cardiovascular disease. World J Cardiol, 6(6):462-477.

[25]Menghini R, Stöhr R, Federici M, 2014. MicroRNAs in vascular aging and atherosclerosis. Ageing Res Rev, 17:68-78.

[26]Murdaca G, Colombo BM, Cagnati P, et al., 2012. Endothelial dysfunction in rheumatic autoimmune diseases. Atherosclerosis, 224(2):309-317.

[27]Newby AC, 2008. Metalloproteinase expression in monocytes and macrophages and its relationship to atherosclerotic plaque instability. Arterioscler Thromb Vasc Biol, 28(12):2108-2114.

[28]Prisco AR, Hoffmann BR, Kaczorowski CC, et al., 2016. Tumor necrosis factor α regulates endothelial progenitor cell migration via CADM1 and NF-κB. Stem Cells, 34(7):1922-1933.

[29]Santhekadur PK, Das SK, Gredler R, et al., 2012. Multifunction protein staphylococcal nuclease domain containing 1 (SND1) promotes tumor angiogenesis in human hepatocellular carcinoma through novel pathway that involves nuclear factor κB and miR-221. J Biol Chem, 287(17):13952-13958.

[30]Shannon P, Markiel A, Ozier O, et al., 2003. Cytoscape: a software environment for integrated models of biomolecular interaction networks. Genome Res, 13(11):2498-2504.

[31]Shiao MS, Chang AYF, Liao BY, et al., 2012. Transcriptomes of mouse olfactory epithelium reveal sexual differences in odorant detection. Genome Biol Evol, 4(5):703-712.

[32]Song DM, Fang GQ, Mao SZ, et al., 2018. Selective inhibition of endothelial NF-κB signaling attenuates chronic intermittent hypoxia-induced atherosclerosis in mice. Atherosclerosis, 270:68-75.

[33]Song Y, Wu ZC, Ding W, et al., 2018. NF-κB in mitochondria regulates PC12 cell apoptosis following lipopolysaccharide-induced injury. J Zhejiang Univ-Sci B (Biomed & Biotechnol), 19(6):425-435.

[34]Steyers CM III, Miller FJ Jr, 2014. Endothelial dysfunction in chronic inflammatory diseases. Int J Mol Sci, 15(7):11324-11349.

[35]Sun SC, Ganchi PA, Ballard DW, et al., 1993. NF-κB controls expression of inhibitor IκBα: evidence for an inducible autoregulatory pathway. Science, 259(5103):1912-1915.

[36]Sun XH, He SL, Wara AKW, et al., 2014. Systemic delivery of microRNA-181b inhibits nuclear factor-κB activation, vascular inflammation, and atherosclerosis in apolipoprotein E-deficient mice. Circ Res, 114(1):32-40.

[37]Tousoulis D, Koutsogiannis M, Papageorgiou N, et al., 2010. Endothelial dysfunction: potential clinical implications. Minerva Med, 101(4):271-284.

[38]Vanhoutte PM, 2009. Endothelial dysfunction: the first step toward coronary arteriosclerosis. Circ J, 73(4):595-601.

[39]Varley CL, Armitage S, Hassanshahiraviz G, et al., 2003. Regulation of the C-X-C chemokine, mob-1, gene expression in primary rat hepatocytes. Cytokine, 23(3):64-75.

[40]Vincenti MP, Coon CI, Brinckerhoff CE, 1998. Nuclear factor κB/p50 activates an element in the distal matrix metalloproteinase 1 promoter in interleukin-1β-stimulated synovial fibroblasts. Arthritis Rheum, 41(11):1987-1994.

[41]Wei W, Zhang WY, Bai JB, et al., 2016. The NF-κB-modulated microRNAs miR-195 and miR-497 inhibit myoblast proliferation by targeting Igf1r, Insr and cyclin genes. J Cell Sci, 129(1):39-50.

[42]Widlansky ME, Gokce N, Keaney JF Jr, et al., 2003. The clinical implications of endothelial dysfunction. J Am Coll Cardiol, 42(7):1149-1160.

[43]Xing YJ, Zhou F, Wang JK, 2013. Subset of genes targeted by transcription factor NF-κB in TNFα-stimulated human HeLa cells. Funct Integr Genomics, 13(1):143-154.

[44]Yang JCS, Wu SC, Rau CS, et al., 2015. TLR4/NF-κB-responsive microRNAs and their potential target genes: a mouse model of skeletal muscle ischemia-reperfusion injury. Biomed Res Int, 2015:410721.

[45]Zampetaki A, Dudek K, Mayr M, 2013. Oxidative stress in atherosclerosis: the role of microRNAs in arterial remodeling. Free Radic Biol Med, 64:69-77.

[46]Zhang HC, Taylor WR, Joseph G, et al., 2013. mRNA-binding protein ZFP36 is expressed in atherosclerotic lesions and reduces inflammation in aortic endothelial cells. Arterioscler Thromb Vasc Biol, 33(6):1212-1220.

[47]Zhou F, Wang W, Xing YJ, et al., 2014. NF-κB target microRNAs and their target genes in TNFα-stimulated HeLa cells. Biochim Biophys Acta, 1839(4):344-354.

[48]Zhou F, Xu XH, Wang DY, et al., 2017. Identification of novel NF-κB transcriptional targets in TNFα-treated HeLa and HepG2 cells. Cell Biol Int, 41(5):555-569.

[49]Zhu BB, Ye J, Ashraf U, et al., 2016. Transcriptional regulation of miR-15b by c-Rel and CREB in Japanese encephalitis virus infection. Sci Rep, 6:22581.

[50]Zhu J, Zhu LWS, Yang JH, et al., 2018. Proteomic analysis of human umbilical vein endothelial cells exposed to PM_2.5. J Zhejiang Univ-Sci B (Biomed & Biotechnol), 19(6):458-470.

[51]List of electronic supplementary materials

[52]Table S1 NF-κB-regulated genes in the TNFα-treated pMVECs